ICD-10 Code B44.7 | Disseminated aspergillosis Symptoms, Diagnosis, Billing

Disseminated aspergillosis is a severe fungal infection caused by the Aspergillus species, primarily affecting immunocompromised individuals. It can lead to widespread organ involvement and significant morbidity. Accurate coding with ICD-10 Code B44.7 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this critical condition.

What is ICD-10 Code B44.7 for Disseminated aspergillosis?

ICD-10 Code B44.7 represents disseminated aspergillosis, a serious fungal infection characterized by the spread of Aspergillus species throughout the body, often in patients with weakened immune systems. This code should be used in clinical documentation and billing when diagnosing patients with confirmed or suspected disseminated aspergillosis, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.

ICD-10 Code B44.7 – Clinical Definition and Explanation of Disseminated aspergillosis

Disseminated aspergillosis is primarily caused by the inhalation of Aspergillus spores, leading to systemic infection, particularly in immunocompromised patients. The condition can progress rapidly, necessitating prompt medical intervention to prevent severe complications and mortality.

Key Clinical Features:

• Commonly presents with fever, cough, and respiratory distress.
• Can lead to organ failure, particularly in the lungs, brain, and kidneys.
• Often associated with underlying conditions such as neutropenia or chronic lung disease.
• Diagnosis typically confirmed through imaging studies and culture of affected tissues.

ICD-10 Code B44.7 for Disseminated aspergillosis – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code B44.7 is utilized to document the patient's symptoms, assessment findings, and treatment plans related to disseminated aspergillosis. This code is relevant in both acute and chronic care settings, facilitating comprehensive patient management and accurate billing.

What Does ICD-10 Code B44.7 for Disseminated aspergillosis Mean in SOAP Notes?

ICD-10 Code B44.7 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of disseminated aspergillosis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B44.7 – Disseminated aspergillosis

Disseminated aspergillosis requires urgent medical attention, often necessitating hospitalization for effective management.

Antibiotic Therapy:

• First-line: Voriconazole or Amphotericin B, typically for 6-12 weeks.
• Alternative: Isavuconazole for patients intolerant to first-line therapies.
• Consider combination therapy in severe cases.

Supportive Care:

• Manage symptoms with oxygen therapy and bronchodilators as needed.
• Monitor renal and liver function due to potential drug toxicity.
• Provide nutritional support and hydration.

Infection Control:

• Implement strict isolation precautions for immunocompromised patients.
• Educate staff on fungal infection prevention measures.
• Conduct environmental assessments to minimize exposure to Aspergillus spores.

How to Document Symptoms of Disseminated aspergillosis (ICD-10 B44.7) in SOAP Notes

Subjective:

• Patient reports persistent fever and cough for several days.
• History of recent chemotherapy and neutropenia.
• Complaints of shortness of breath and fatigue.

Objective:

• Auscultation reveals bilateral crackles.
• Respiratory rate: 24 breaths per minute.
• Oxygen saturation: 88% on room air.
• Chest X-ray shows infiltrates consistent with fungal infection.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Disseminated aspergillosis (ICD-10 Code B44.7)

Assessment:

• Disseminated aspergillosis, severe, ICD-10 B44.7.
• Patient is immunocompromised due to recent chemotherapy.
• Common triggers include neutropenia and environmental exposure.

Plan:

• Initiate voriconazole therapy and monitor for side effects.
• Educate patient on signs of worsening respiratory distress.
• Schedule follow-up imaging in one week to assess treatment response.
• Consider consultation with infectious disease specialist.

Treatment & Plan Section for ICD-10 Code B44.7 – Disseminated aspergillosis

• Administer antifungal therapy as per guidelines.
• Implement infection control measures to protect vulnerable patients.
• Monitor clinical response and adjust treatment based on laboratory results.
• Provide patient education on the importance of adherence to therapy.

Using ICD-10 Code B44.7 for Disseminated aspergillosis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
• Use B44.7 in conjunction with relevant procedure codes for billing.
• Maintain compliance with coding guidelines to support reimbursement.
• Document any complications or comorbidities that may affect treatment.

Related ICD-10 Codes Often Used with Disseminated aspergillosis

• B44.0 – Aspergillosis, pulmonary
• B44.1 – Aspergillosis, allergic
• B44.9 – Aspergillosis, unspecified

ICD-10 Code B44.7 in Medical Billing and Insurance for Disseminated aspergillosis

ICD-10 Code B44.7 is crucial for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the use of B44.7.
• Ensure that the diagnosis is clearly linked to the patient's treatment plan.
• Use B44.7 in conjunction with procedure codes for comprehensive billing.

Common CPT Pairings: